CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

‘Last roll of the dice’ for a near-term HIV vaccine fails

A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in

December 6, 2023

Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions – Pharmaceutical Technology

As biosimilars enter the psoriasis market, key opinion leaders anticipate a shift in patient preference from IL-23 therapies to IL-17 therapies due to pricing and

October 31, 2024

Accelerating Progress in Cardiac Care with AI-Enabled Analysis

Stuart Long, CEO, InfoBionic Cardiac Health is Top of Mind. The Quest to ‘Zero’ Avoidable Cardiac-Related Deaths Continues. Cardiac disease is one of the top

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.